Phase II Clinical Chemoprevention Trial of Weekly Erlotinib before Bladder Cancer Surgery.
Downs TM, Bailey HH, Lozar T, Schmitz NS, Green H, Scarlett CO, Havighurst TC, Twaroski K, DeShong K, Wollmer B, Bivalacqua TJ, Saltzstein DR, Shore N, Kim K, Huang W, Ricke WA, Barroilhet L, House M, Parnes HL, Messing E.
Downs TM, et al. Among authors: deshong k.
Cancer Prev Res (Phila). 2025 Jan 6;18(1):31-39. doi: 10.1158/1940-6207.CAPR-24-0194.
Cancer Prev Res (Phila). 2025.
PMID: 39187984
Clinical Trial.